SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $290,000 | -75.7% | 100,000 | -62.7% | 0.08% | -82.0% |
| Q2 2017 | $1,192,000 | +27.9% | 267,800 | +33.9% | 0.47% | +71.4% |
| Q1 2017 | $932,000 | -59.0% | 200,000 | -51.5% | 0.28% | -60.0% |
| Q3 2016 | $2,273,000 | +70.9% | 412,500 | +17.9% | 0.69% | +22.1% |
| Q2 2016 | $1,330,000 | -15.9% | 350,000 | -38.9% | 0.56% | -21.4% |
| Q1 2016 | $1,581,000 | -25.2% | 572,800 | +53.6% | 0.72% | -19.4% |
| Q4 2015 | $2,114,000 | -0.3% | 372,800 | -6.8% | 0.89% | -26.3% |
| Q3 2015 | $2,120,000 | -5.6% | 400,000 | +62.4% | 1.21% | +5.3% |
| Q2 2015 | $2,246,000 | +49.7% | 246,250 | -24.2% | 1.15% | +48.4% |
| Q1 2015 | $1,500,000 | +96.6% | 324,700 | +29.9% | 0.77% | +175.4% |
| Q4 2014 | $763,000 | – | 250,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
| Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
| Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
| KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
| Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
| Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
| Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
| Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |